OBI-888

· OBI Pharma, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OBI-888, covering 2024-02-22 to 2024-02-22. Get the full timeline:

Most recent: Clinical Trial Update: This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. [Phase 1, Phase 2]

See pricing